James Liao to Angiotensin II Type 1 Receptor Blockers
This is a "connection" page, showing publications James Liao has written about Angiotensin II Type 1 Receptor Blockers.
Mineralocorticoid receptor blocker eplerenone improves endothelial function and inhibits Rho-associated kinase activity in patients with hypertension. Clin Pharmacol Ther. 2012 Feb; 91(2):289-97.
Calcium channel blocker and Rho-associated kinase activity in patients with hypertension. J Hypertens. 2011 Feb; 29(2):373-9.
Role of angiotensin II receptor subtypes in porcine basilar artery: functional, radioligand binding, and cell culture studies. Life Sci. 2006 Jan 25; 78(9):943-9.